Abstract
The preferentially expressed antigen in melanoma (PRAME) gene is aberrantly expressed in chronic lymphoproliferative disorders (CLD). We produced and characterized an anti-PRAME monoclonal antibody (MoAb), which was then applied in a quantitative flow cytometric (QFC) method to evaluate PRAME expression in leukemic cells from the peripheral blood (PB) of 47 patients with chronic lymphocytic leukemia and seven with mantle cell lymphoma as well as in the PB mononuclear cells (PBMCs) and B lymphocytes from 15 healthy subjects. Approximately 90% of CLD, but none of the normal samples, presented more than 20% of PRAME+ lymphocytes. Moreover, the intensity of PRAME expression was significantly higher in CLD cells compared to normal B lymphocytes and PBMCs. By immunofluorescence microscopy and by permeabilized flow cytometry we demonstrated that PRAME is a membrane antigen and a cytoplasmic protein aberrantly expressed in malignant CLD. Our results suggest that the analysis of PRAME protein may contribute for the distinction between normal and leukemic cells in CLD, and that PRAME may be a potential target for therapy.
References
Aug 1, 1997·Melanoma Research·B LethéT Boon
Jun 10, 1998·Experimental and Clinical Immunogenetics·A F KirkinJ Zeuthen
Sep 30, 1998·British Journal of Haematology·N van BarenP G Coulie
Apr 12, 2001·British Journal of Haematology·M MatsushitaY Kawakami
May 9, 2001·Nucleic Acids Research·M W Pfaffl
Feb 2, 2002·Nature·Laura J van 't VeerStephen H Friend
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Nov 7, 2002·Cancer Genetics and Cytogenetics·Daniel SteinbachBernd Gruhn
Jul 9, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·André OberthuerMatthias Fischer
Aug 17, 2005·Cancer Research·Nicolas TajeddinePhilippe Gailly
Sep 24, 2005·Cell·Mirjam T EppingRené Bernards
Citations
Jul 13, 2007·Breast Cancer Research and Treatment·Padraig DoolanLorraine O'Driscoll
Mar 2, 2011·International Journal of Hematology·Adam J LinleyRobert C Rees
Sep 15, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Ulrike GerdemannAnn M Leen
Sep 15, 2010·Oncogene·D D De CarvalhoG P Amarante-Mendes
May 20, 2011·Leukemia Research·Bu Yin
Apr 23, 2010·Leukemia Research·Tim LuetkensDjordje Atanackovic
Nov 26, 2008·Leukemia Research·Shelly R GunnRyan S Robetorye
Apr 11, 2008·Leukemia Research·Semra Paydas
Feb 26, 2008·Leukemia Research·Evgeny AronsRobert J Kreitman
Mar 7, 2012·Biochemical and Biophysical Research Communications·Pingxian TanJingnian Shen
Apr 15, 2017·The Cancer Journal·David A Braun, Catherine J Wu
Dec 7, 2010·American Journal of Hematology·Jonathan M GerberRichard J Jones
Oct 17, 2017·Oncotarget·Dmitry PankovDavid Ulmert
Oct 11, 2017·British Journal of Haematology·Francesca MestichelliPiero Galieni
Jul 18, 2019·Cancers·Ghaneya Al-Khadairi, Julie Decock
Jan 29, 2021·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Spyridoula VasileiouGeorge Carrum
Apr 4, 2021·International Journal of Molecular Sciences·Jwala Priyadarsini SivaccumarAnnamaria Sandomenico
Aug 31, 2010·Molecular Cancer·Frances WadelinDavid M Heery